Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-14T06:41:19.535Z Has data issue: false hasContentIssue false
  • English
  • Français

Basic science: (January 2009)

Published online by Cambridge University Press:  01 August 2009

R. Sutherland
R. Sutherland
Affiliation:
Cancer Research ProgramGarvan Institute of Medical ResearchDarlinghurst, NSW, Australia

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Journals Watch
Information
Breast Cancer Online , Volume 12 , Issue 8 , August 2009 , e13
Copyright
Copyright © Cambridge University Press 2009

References

1.Andre, F, Job, B, Dessen, P, Tordai, A, Michiels, S, Liedtke, C, Richon, C, Yan, K, Wang, BL, Vassal, G, Delaloge, S, Hortobagyi, GN, Symmans, WF, Lazar, V, Pusztai, L. Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array. Clin Cancer Res 2009; 15: 441–451.CrossRefGoogle ScholarPubMed
2.Berg, AO, Grp, EW, Armstrong, K, Botkin, J, Calonge, N, Haddow, J, Hayes, M, Kaye, C, Phillips, KA, Piper, M, Richards, CS, Scott, JA, Strickland, OL, Teutsch, S. Recommendations from the EGAPP Working Group: can tumor gene expression profiling improve outcomes in patients with breast cancer? Genet Med 2009; 11: 66–73.Google Scholar
3.Bourguignon, LYW, Xia, WL, Wong, G. Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NF kappa B-specific transcription activity leading to MDR1 and Bcl-x(L) gene expression and chemoresistance in breast tumor cells. J Biol Chem 2009; 284: 2657–2671.CrossRefGoogle Scholar
4.Crane, CA, Panner, A, Murray, JC, Wilson, SP, Xu, H, Chen, L, Simko, JP, Waldman, FM, Pieper, RO, Parsa, AT. PI(3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer. Oncogene 2009; 28: 306–312.CrossRefGoogle ScholarPubMed
5.de Muga, SV, Timpson, P, Cubells, L, Evans, R, Hayes, TE, Rentero, C, Hegemann, A, Reverter, M, Leschner, J, Pol, A, Tebar, F, Daly, RJ, Enrich, C, Grewal, T. Annexin A6 inhibits Ras signalling in breast cancer cells. Oncogene 2009; 28: 363–377.CrossRefGoogle Scholar
6.Ding, SL, Yu, JC, Chen, ST, Hsu, GC, Kuo, SJ, Lin, YH, Wu, PE, Shen, CY. Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility. Carcinogenesis 2009; 30: 43–49.CrossRefGoogle ScholarPubMed
7.Feres, KJ, Ischenko, I, Hayman, MJ. The RON receptor tyrosine kinase promotes MSP-independent cell spreading and survival in breast epithelial cells. Oncogene 2009; 28: 279–288.CrossRefGoogle ScholarPubMed
8.Ghayad, SE, Vendrell, JA, Bieche, I, Spyratos, F, Dumontet, C, Treilleux, I, Lidereau, R, Cohen, PA. Identification of TACC1, NOV, and PTTG1 as new candidate genes associated with endocrine therapy resistance in breast cancer. J Mol Endocrinol 2009; 42: 87–103.CrossRefGoogle ScholarPubMed
9.Hu, ZB, Liang, J, Wang, ZW, Tian, T, Zhou, XY, Chen, JP, Miao, RF, Wang, Y, Wang, XR, Shen, HB. Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat 2009; 30: 79–84.CrossRefGoogle ScholarPubMed
10.Kok, M, Linn, SC, Van Laar, RK, Jansen, M, van den Berg, TM, Delahaye, L, Glas, AM, Peterse, JL, Hauptmann, M, Foekens, JA, Klijn, JGM, Wessels, LFA, Van’t Veer, LJ, Berns, E. Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen. Breast Cancer Res Treat 2009; 113: 275–283.CrossRefGoogle ScholarPubMed
11.Lower, EE, Glass, E, Blau, R, Harman, S. HER-2/neu expression in primary and metastatic breast cancer. Breast Cancer Res Treat 2009; 113: 301–306.CrossRefGoogle ScholarPubMed
12.Lund, MJ, Trivers, KF, Porter, PL, Coates, RJ, Leyland-Jones, B, Brawley, OW, Flagg, EW, O’Regan, RM, Gabram, SGA, Eley, JW. Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat 2009; 113: 357–370.CrossRefGoogle ScholarPubMed
13.Luo, M, Fan, HP, Nagy, T, Wei, HJ, Wang, CR, Liu, SL, Wicha, MS, Guan, JL. Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells. Cancer Res 2009; 69: 466–474.CrossRefGoogle ScholarPubMed
14.Manie, E, Vincent-Salomon, A, Lehmann-Che, J, Pierron, G, Turpin, E, Warcoin, M, Gruel, N, Lebigot, I, Sastre-Garau, X, Lidereau, R, Remenieras, A, Feunteun, J, Delattre, O, de The, H, Stoppa-Lyonnet, D, Stern, MH. High frequency of TP53 mutation in BRCA1 and sporadic basal-like carcinomas but not in BRCA1 luminal breast tumors. Cancer Res 2009; 69: 663–671.CrossRefGoogle Scholar
15.Meijer, D, Jansen, M, Look, MP, Ruigrok-Ritstier, K, van Staveren, IL, Sieuwerts, AM, van Agthoven, T, Foekens, JA, Dorssers, LCJ, Berns, E. TSC22D1 and PSAP predict clinical outcome of tamoxifen treatment in patients with recurrent breast cancer. Breast Cancer Res Treat 2009; 113: 253–260.CrossRefGoogle ScholarPubMed
16.Millar, EK, Anderson, LR, McNeil, CM, O’Toole, SA, Pinese, M, Crea, P, Morey, AL, Biankin, AV, Henshall, SM, Musgrove, EA, Sutherland, RL, Butt, AJ. BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast. Br J Cancer 2009; 100: 123–133.CrossRefGoogle ScholarPubMed
17.Mirzoeva, OK, Das, D, Heiser, LM, Bhattacharya, S, Siwak, D, Gendelman, R, Bayani, N, Wang, NJ, Neve, RM, Guan, Y, Hu, Z, Knight, Z, Feiler, HS, Gascard, P, Parvin, B, Spellman, PT, Shokat, KM, Wyrobek, AJ, Bissell, MJ, McCormick, F, Kuo, WL, Mills, GB, Gray, JW, Korn, WM. Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibition. Cancer Res 2009; 69: 565–572.CrossRefGoogle ScholarPubMed
18.Mourtada-Maarabouni, M, Pickard, MR, Hedge, VL, Farzaneh, F, Williams, GT. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene 2009; 28: 195–208.CrossRefGoogle ScholarPubMed
19.Pilones, KA, Kawashima, N, Yang, AM, Babb, JS, Formenti, SC, Demaria, S. Invariant natural killer T cells regulate breast cancer response to radiation and CTLA-4 blockade. Clin Cancer Res 2009; 15: 597–606.CrossRefGoogle ScholarPubMed
20.Smith, AP, Verrecchia, A, Faga, G, Doni, M, Perna, D, Martinato, F, Guccione, E, Amati, B. A positive role for Myc in TGF beta-induced snail transcription and epithelial-to-mesenchymal transition. Oncogene 2009; 28: 422–430.CrossRefGoogle Scholar
21.Strecker, TE, Shen, Q, Zhang, Y, Hill, JL, Li, YX, Wang, C, Kim, HT, Gilmer, TM, Sexton, KR, Hilsenbeck, SG, Osborne, CK, Brown, PH. Effect of lapatinib on the development of estrogen receptor-negative mammary tumors in mice. J Natl Cancer Inst 2009; 101: 107–113.CrossRefGoogle ScholarPubMed
22.Tan, EY, Yan, M, Campo, L, Han, C, Takano, E, Turley, H, Candiloro, I, Pezzella, F, Gatter, KC, Millar, EKA, O’Toole, SA, McNeil, CM, Crea, P, Segara, D, Sutherland, RL, Harris, AL, Fox, SB. The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy. Br J Cancer 2009; 100: 405–411.CrossRefGoogle ScholarPubMed
23.Tchatchou, S, Jung, A, Hemminki, K, Sutter, C, Wappenschmidt, B, Bugert, P, Weber, BHF, Niederacher, D, Arnold, N, Varon-Mateeva, R, Ditsch, N, Meindl, A, Schmutzler, RK, Bartram, CR, Burwinkel, B. A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women. Carcinogenesis 2009; 30: 59–64.CrossRefGoogle ScholarPubMed
24.Thomassen, M, Tan, QH, Kruse, TA. Gene expression meta-analysis identifies chromosomal regions and candidate genes involved in breast cancer metastasis. Breast Cancer Res Treat 2009; 113: 239–249.CrossRefGoogle ScholarPubMed
25.Wang, SE, Xiang, B, Zent, R, Quaranta, V, Pozzi, A, Arteaga, CL. Transforming growth factor beta induces clustering of HER2 and integrins by activating Src-focal adhesion kinase and receptor association to the cytoskeleton. Cancer Res 2009; 69: 475–482.CrossRefGoogle ScholarPubMed
26.Wu, F, Ivanov, I, Xu, R, Safe, S. Role of SP transcription factors in hormone-dependent modulation of genes in MCF-7 breast cancer cells: microarray and RNA interference studies. J Mol Endocrinol 2009; 42: 19–33.CrossRefGoogle ScholarPubMed
27.Zhao, XS, Lu, L, Pokhriyal, N, Ma, H, Duan, L, Lin, S, Jafari, N, Band, H, Band, V. Overexpression of RhoA induces preneoplastic transformation of primary mammary epithelial cells. Cancer Res 2009; 69: 483–491.CrossRefGoogle ScholarPubMed